Wei AH, Dohner H, Sayar H, Ravandi F, et al. Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial. Am J Hematol 2023 Jan 19. doi: 10.1002/ajh.26847.
PMID: 36655608